GlassScriptPhysician profile
Casey Carter Nazor
NPI 1346503323
$10,143.46
in general payments reported to CMS, 2019-2025
61 companies · $1,322 in 2025
The $1,322 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,423 · 2020: $1,118 · 2021: $1,944 · 2022: $1,964 · 2023: $876 · 2024: $1,497 · 2025: $1,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,607 · Education: $87.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,606.76 |
| Education | $87.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,210.13 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $864.81 | 2019-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Acadia Pharmaceuticals INC | $702.34 | 2019-2025 | Nuplazid, Daybue |
| Lilly USA, LLC | $667.22 | 2019-2025 | Kisunla, Amyvid, Reyvow |
| Novartis Pharmaceuticals Corporation | $494.53 | 2019-2025 | |
| Emd Serono, INC. | $430.58 | 2019-2025 | Mavenclad |
| Amneal Pharmaceuticals LLC | $427.78 | 2019-2024 | Rytary |
| Biogen, INC. | $315.92 | 2019-2025 | Vumerity, Leqembi, Tysabri |
| Amgen INC. | $314.20 | 2019-2025 | Uplizna, Aimovig |
| Upsher-Smith Laboratories LLC | $294.60 | 2019-2022 | |
| Neurelis, INC. | $284.17 | 2020-2025 | Valtoco |
| Acorda Therapeutics, INC | $248.10 | 2019-2023 | Inbrija, Ampyra |
| Impel Pharmaceuticals INC. | $238.44 | 2022-2023 | Trudhesa |
| Lundbeck LLC | $228.64 | 2019-2025 | Vyepti |
| Takeda Pharmaceuticals U.S.A., INC. | $206.63 | 2023-2025 | Hyqvia, Gammagard |
Show all 61 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Nazor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.